Vaxart, Inc. Purchase Agreements
12 Contracts & Agreements
- Securities Purchase Agreement, dated January 16, 2024, by and between Vaxart, Inc. and RA Capital Healthcare Fund, L.P (Filed With SEC on January 16, 2024)
- Asset Purchase Agreement, dated November 24, 2021, by and between Vaxart, Inc. and Kindred Biosciences, Inc (Filed With SEC on February 24, 2022)
- Form of Securities Purchase Agreement, dated February 27, 2020, among the Company and the Purchasers named therein (Filed With SEC on March 2, 2020)
- Form of Securities Purchase Agreement, dated as of March 19, 2019, by and among Vaxart, Inc. and the Purchasers named therein (Filed With SEC on March 20, 2019)
- ASSET PURCHASE AGREEMENT by and between NABI BIOPHARMACEUTICALS and (Filed With SEC on November 5, 2009)
- ASSET PURCHASE AGREEMENT (Filed With SEC on September 11, 2007)
- SECOND AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on March 15, 2007)
- FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on March 15, 2007)
- ASSET PURCHASE AGREEMENT between NABI BIOPHARMACEUTICALS (the Seller) and (Filed With SEC on March 15, 2007)
- PLASMA PURCHASE AGREEMENT AMENDMENT (Filed With SEC on November 14, 2006)
- PLASMA PURCHASE AGREEMENT (Filed With SEC on November 14, 2006)
- EX-10.3 Asset Purchase Agreement (Filed With SEC on July 25, 2003)
